Proteome Sciences plc announce Good Clinical Laboratory Practice Accreditation

Proteome Sciences are pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) accreditation which will enable the Company to extend its proteomic services to the analysis of clinical trial samples.

Proteome Sciences are a Contract Research Organisation (CRO) specialising in the analysis of proteins detected by Mass Spectrometry.  They offer various Discovery Services to characterise proteins and their associated post translational modifications.  By using LC-MS2, LC-MS3, SysQuant® and TMTcalibratorTM methodologies on samples that originate from tissue to biological fluids, they can detect many thousands of proteins per sample.  With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.

ELISA kits cover 5% of the human proteome, so there are usually no available assay kits to these disease relevant protein biomarkers.  The challenge has been how to convert these novel identified biomarkers into assays fit for use in a clinical trial.

Following identification above, Proteome Sciences can now a develop a targeted SRM Mass Spectrometry based assay which, after validation, can be used for fit-for-purpose biomarker assays in a GCLP certified clinical trial environment.  This can be done for one to 50 proteins in a single multiplexed assay.

For further information:

Richard Dennis, Chief Commercial Officer         Tel: +44 (0)20 7043 2116



RPS Diagnostics partners with Atomo Diagnostics to develop next generation Febridx blood tests for Antibiotic Stewardship in the Outpatient setting

Sarasota, Florida and Sydney, Australia (February 20, 2018) – United States biotechnology company, ...

Read More >

UK lateral flow rapid test manufacturer Abingdon Health confirms expansion

Following a successful 2019, Abingdon Health is expanding its York-based facility, giving the compan...

Read More >

First multi-site installation of HORIBA Medical’s new HELO modular automated haematology platform

Northampton, UK – 28th May 2019 – HORIBA UK Ltd, Medical announces the go live of the first multi-...

Read More >

SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD ma...

Read More >

EKF Diagnostics publishes ‘Diabetes and HbA1c testing’ guide

Cardiff, UK – 17th July 2017 – EKF Diagnostics, the global in vitro diagnostics company, has publi...

Read More >

DiaSorin and Tecan to collaborate in new platform development

DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under ...

Read More >